LUNGMAP: A MASTER PROTOCOL TO EVALUATE BIOMARKER-DRIVEN THERAPIES AND IMMUNOTHERAPIES IN PREVIOUSLY-TREATED NON-SMALL CELL LUNG CANCER (Lung-MAP Screening Study)
Details
Age
Adult
Type of Study
Screening
Locations
Rocky Mountain Regional VA Medical Center
Principal Investigator
Jessica Mcdermott, MD
Study ID
Protocol Number: 20-1813
More information available at ClinicalTrials.gov: NCT03851445
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers